Given the rarity of CSF3R-mutated myeloid neoplasms outside of CNL and aCML, our cohort represents one of the largest institutional case series described to date. This evidence concerns the gene CSF3R and atypical chronic myeloid leukemia, BCR-ABL1 negative.